anitch® 快訊

保持關注專家分享的護膚、健康及Anitch產品的最新資訊與故事。了解我們如何創新濕疹療法,並獲得健康媒體及社區的廣泛認可。

Anitch® Products Available for Pre-order Now

anitch® 快訊

預購現在開始:Anitch產品已上架!

於 2026 年 3月 26 日
無論您是我們的忠實顧客還是首次體驗,預購都能讓您搶先享受我們修復屏障、呵護肌膚的產品功效。趁熱搶購您的護膚必需品,直接通過我們的網站預訂,確保不會錯過。
Anitch® Joins Watsons Hong Kong: A New Era for Eczema Care

anitch® 快訊

Anitch® Joins Watsons Hong Kong: A New Era for Eczema Care

於 2026 年 3月 11 日
Anitch® skincare is now available at Watsons Hong Kong, bringing innovative, steroid-free eczema care powered by Anesinin® to more people. Discover gentle, science-backed solutions for healthier skin.
Anesinin®: Science for your skin.

anitch® 快訊

安思靈® (Anesinin): 科研護膚配方

於 2025 年 10月 01 日
安思靈® (Anesinin)  是專為 安力施® (Anitch) 濕疹護理系列開發的尖端專有天然配方。與單純保濕或抑制炎症的傳統乳霜不同,安思靈® (Anesinin)  旨在解決濕疹發作的根本原因之一:敏感肌膚上有害細菌(特別是金黃色葡萄球菌,通常稱為「Staph」)的存在和活性。
Living Well

anitch® 快訊

Living Well

於 2025 年 9月 25 日
Rethinking Eczema Care For years, people living with eczema have been told that flare-ups are simply a matter of sensitive skin, dryness, or an overactive immune system. Treatments like steroids and antibiotics have become the standard, offering short-term relief but often leading to side effects, microbiome imbalance, and repeated flare-ups. Today, research tells us a different story: the real culprit behind eczema is Staphylococcus aureus (Staph), a common bacterium that behaves very differently on the skin of eczema patients compared to healthy individuals. With this discovery, a new path to care has opened—one centered on restoring balance instead of fighting against the skin.     Staph: The Hidden Driver of Eczema Staph is found in about 30% of healthy people, usually without causing harm. But in people with eczema, colonization rates soar, and Staph is present on the skin of nearly all patients. For a long time, scientists believed Staph only worsened eczema by causing infections. Now, research from top medical universities has proven that Staph is the primary cause of flare-ups. The reason lies in its ability to release virulence factors—toxins and enzymes that: Trigger strong immune responses Interfere with skin defences Damage the barrier Cause intense itch, redness, and inflammation These factors explain why eczema-prone skin is more vulnerable to flare-ups and why symptoms like itching, oozing, scabbing, and golden crusting often appear when Staph is active. The Flare-Up Cycle When Staph takes hold, the process looks like this: Increased Colonization: People with eczema harbor more Staph on their skin and even in the nasal cavity. Immune Response: Once bacteria breach the barrier, the immune system overreacts, worsening symptoms. Barrier Breakdown: Staph toxins further disrupt defences, keeping skin weak. Ongoing Flare-Ups: The cycle repeats, making healing difficult. Why Traditional Treatments Struggle Steroids suppress inflammation but weaken the immune system over time, causing side effects. Antibiotics kill harmful bacteria but also wipe out the good bacteria your skin needs—and Staph is becoming increasingly resistant. These treatments may quiet symptoms for a while, but they don’t address the real trigger: Staph toxins. A Smarter Solution: Anesinin® Here’s where Anesinin® makes a difference. Instead of killing bacteria or suppressing immunity, this breakthrough bioactive compound blocks Staph’s ability to produce toxins and enzymes. Staph stays on the skin—but in a harmless, non-inflammatory form Flare-up triggers are neutralized at the source The skin barrier is given the chance to rest, recover, and heal naturally This approach marks a true paradigm shift: treating the root cause of eczema while preserving the healthy balance of the microbiome. Living Well with Anitch® At Anitch®, we’ve embraced this science as the heart of our skincare philosophy. By combining Anesinin® with nourishing, gentle ingredients, we’ve developed products that support balance instead of battle. Face Cream: Lightweight daily hydration and barrier support Body Cream: All-over relief for eczema-prone skin Rescue Balm: Intensive care for sudden flare-ups, safe for both face and body Together, they form a complete system designed to calm, protect, and empower your skin for the long term. Conclusion Living well with eczema doesn’t mean relying on harsh drugs or temporary fixes. Thanks to Anesinin®, and the care behind Anitch®, it’s now possible to address the true cause of flare-ups while protecting the skin’s natural ecosystem.
Anesinin®: The Breakthrough Changing Eczema Care

anitch® 快訊

Anesinin®: The Breakthrough Changing Eczema Care

於 2025 年 9月 25 日
Anesinin® blocks Staph toxins that trigger eczema, protecting the skin’s microbiome. Discover how Anitch® brings balance, not battle, to skincare.
How Staph Triggers Eczema — and How Anitch® Brings Relief with Anesinin®

anitch® 快訊

How Staph Triggers Eczema — and How Anitch® Brings Relief with Anesinin®

於 2025 年 9月 23 日
Eczema, or atopic dermatitis, is more than just dry, itchy skin. At its root, scientists have found that Staphylococcus aureus (Staph) bacteria are a major driver of flare-ups. Unlike traditional treatments that suppress the immune system or kill bacteria indiscriminately, new science shows that targeting toxins — not bacteria — is the key to breaking the eczema cycle.
The Skin Microbiome & Eczema: How Tiny Organisms Shape Our Skin Health

anitch® 快訊

The Skin Microbiome & Eczema: How Tiny Organisms Shape Our Skin Health

於 2025 年 9月 22 日
Eczema flare-ups? Science points to one culprit: Staphylococcus aureus. But new research shows friendly bacteria may hold the key to restoring balance. Explore the future of eczema care in our latest blog. 
Anesinin®

anitch® 快訊

安思靈® (Anesinin)

於 2025 年 9月 22 日
濕疹(異位性皮膚炎)的成因似乎有多方面,而核心因素主要與免疫系統功能失調(過度活躍)有關。然而,近年有研究發現,皮膚上細菌在濕疹發病機制中起著關鍵角色,這個新理論得到越來越多證據支持。事實上,濕疹患者皮膚上某些細菌的高度定殖,更加強了這個觀點的可信性。   細菌定殖與濕疹之間的關係非常複雜,細菌可加劇皮膚炎症和皮膚屏障功能障礙,進而參與濕疹的發病過程。另外,皮膚上存在某些細菌品種時,亦可能誘發免疫反應,令濕疹症狀進一步惡化。 安力施® (Anitch) 致力於研究與發掘大自然中的天然解決方案,並用於治療濕疹。經過多年和知名大學進行的深入研究,我們開發了安思靈® (Anesinin),它是由一些獨特的天然生物活性分子組成,可有效抑制細菌的毒性,從而減低引發濕疹的病發。安思靈與現有的濕疹治療相比,它只作用於皮膚上的有害細菌,並不含免疫抑制劑 (如類固醇、PDE4、JAK等),從而避免了免疫抑制劑所帶來的副作用。 總體來說,以安思靈為基礎的局部皮膚護理將是革命性的,可能會進一步促成現行濕疹治療模式的轉型,提供無需免疫抑制劑的抗炎新選擇。